Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-12 | 2024-03-22 | 215973 |
APO-SOTALOL | 160MG | TABLET | Resolved | 2024-01-12 | 2024-01-19 | 215976 |
APO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-12 | 2024-02-09 | 215979 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-01-19 | 2024-03-22 | 216653 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2024-01-19 | 2024-02-23 | 216656 |
APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2024-01-19 | 2024-02-09 | 216659 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2024-01-19 | 2024-02-09 | 216672 |
APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-01-19 | 2024-03-29 | 216675 |
APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2024-01-19 | 2024-03-22 | 216678 |
APO-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-19 | 2024-02-23 | 216681 |
APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-02-23 | 217300 |
APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2024-01-26 | 2024-04-05 | 217469 |
APO-MIDODRINE | 5MG | TABLET | Resolved | 2024-01-26 | 2024-05-24 | 217472 |
ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2024-01-26 | 2024-03-08 | 217475 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-01-26 | 2024-02-16 | 217478 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-05-31 | 217481 |
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-01-26 | 2024-03-15 | 217487 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 |